News & Events about Annovis Bio.
TipRanks Financial Blog
1month ago
Maxim Group analyst Jason McCarthy maintained a Buy rating on Annovis Bio (ANVS Research Report) yesterday and set a price target of $26.00. The ... Maxim Group analyst Jason McCarthy maintained a Buy rating on Annovis Bio (ANVS Res...
ANNOVIS BIO RAISES AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $8.7 MILLION ANNOVIS BIO RAISES AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $8.7 MILLION PR Newswire BERWYN, Pa., April 11, 2023 BERWYN, Pa., April 11, 2023 /PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ('Annovis' or the...
Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease Annovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease PR...
Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team PR Newswire BERWYN, Penn., Jan. 6, 2023 BERWYN, Penn., Jan. 6, 2023 /PRNewswire/ --Annovis Bio, Inc.(NYSE:ANVS) ('Annovis' or the...